Slide to be completed for Assay. If possible please find two more metabolic disorder possibilities to compare to in addition to NARP.
Presentation speech to be completed for both Kearns-Sayre Syndrome (Slide 2) and assay (Slide 3). 5min presentation.
Elements including; Robustness (cope with small changes in the assay sample/equipment/operator), Precision (accurate concentration), Performance (statistically robust across different conditions), are embedded within the foregoing and addressed.
• identify, and develop differential diagnosis protocol, treatment option(s), prognosis and current research effort, through a series of experimental Modules 1-4 focusing on Biochemical Assay Development
o Using the Work Integrated Learning (WIL) industry standard assay as an industry standard template/protocol determine the WIL assay outcome for Patient F in order to compare and contrast biochemical assays.
• Test assay ‘reproducibility’ by determining Quality Control sample attributes and values. Mention assay low inter- and intra-assay variability.